Kamada Ltd

-0.11 (-1.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)277.74M
Current PE22.98
Forward PE 89.71
2yr Forward PE 25.12
See more stats
Estimates Current Quarter
Revenue$23.36 Million
Adjusted EPS$0.01
See more estimates
10-Day MA$6.03
50-Day MA$5.56
200-Day MA$5.80
See more pivots

Kamada Ltd Stock, NASDAQ:KMDA

Science Park, 2 Holzman Street, Rehovot, HaMerkaz 7670402
Phone: +972.8.940.6472
Number of Employees: 408


Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following segments: Proprietary Products and Distribution. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.